Leidos(US:LDOS)2025-05-06 12:00Financial Data and Key Metrics Changes - In Q1 2025, organic revenue increased by 7% year over year, reaching $4.25 billion [25] - Adjusted EBITDA was $601 million, up 23% year over year, with an adjusted EBITDA margin of 14.2%, an increase of 190 basis points [26] - Non-GAAP diluted earnings per share rose by 30% to $2.97, with non-GAAP net income at $391 million [26] Business Line Data and Key Metrics Changes - National Security and Digital revenues increased by 5% year over year, with a non-GAAP operating income margin of 10.1% [26] - Health and Civil revenues grew by 8% year over year, with a non-GAAP operating income margin of 23.6% [27] - Commercial International revenues rose by 12% year over year, with non-GAAP operating margins at 8.5% [27] - Defense Systems revenues increased by 7% year over year, with non-GAAP operating margins expanding by 110 basis points to 9.1% [28] Market Data and Key Metrics Changes - The company reported a total backlog of $46.3 billion, up approximately $3 billion from the previous quarter [35] - Net bookings for the quarter were $2.1 billion, resulting in a trailing twelve-month book-to-bill ratio of 1.3 [35] Company Strategy and Development Direction - The company is implementing its North Star 02/1930 strategy, focusing on five growth pillars: space and maritime, energy infrastructure, digital modernization and cyber, customized critical mission software, and managed health services [10][12] - The strategy aligns with the new administration's priorities, emphasizing smarter and more efficient government outcomes [13][14] - The company has accelerated its share buyback program with a $500 million agreement and announced a definitive agreement to acquire a cyber leader to enhance its capabilities [15][18] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the current geopolitical environment and the administration's focus on modernization and efficiency, which aligns with the company's capabilities [8][19] - The company reaffirmed its full-year 2025 guidance, expecting revenue between $16.9 billion and $17.3 billion, adjusted EBITDA in the mid to high 12% range, and non-GAAP diluted EPS between $10.35 and $10.75 [34] Other Important Information - The company generated $58 million in cash flows from operating activities and $36 million in free cash flow during the quarter [29] - The company ended the quarter with $5.1 billion in debt and $842 million in cash and cash equivalents [33] Q&A Session Summary Question: How are larger contracts like NGEN performing under the current contracting environment? - Management noted a negligible impact on revenue from macro actions, with a low 1% range effect, while also seeing opportunities in the DoD for additional acquisitions and modernizations [40][41] Question: Can you provide insights on the GSA request regarding potential contract offerings? - Management confirmed active engagement with the GSA, focusing on how to make government operations smarter and more efficient, emphasizing their mission-critical work [48][50] Question: What are the opportunities in the VA's EHR modernization work? - Management expressed optimism about growth in managed health services, anticipating increased volumes and opportunities to expand offerings in the future [54][56] Question: What are the implications of the supplemental defense bill? - Management highlighted significant opportunities in FAA modernization and border security, aligning with the company's growth pillars [62] Question: How does the company view the potential for revenue decline in the next three years? - Management does not envision a revenue decline, citing strong alignment of growth pillars with customer needs and administration priorities [110][112]